Marijuana Stocks: What Could Push Canopy Growth Corp. Stock to $40?

Canopy Growth Corp. (TSX:WEED) stock has lost its momentum this year after producing triple-digit gains in 2017. Find out what’s stopping marijuana stocks to move higher from here.

| More on:

Canopy Growth Corp. (TSX:WEED) stock has been trading in a range for the past month, and investors, who were witnessing explosive gains in marijuana shares, are now wondering what might take this top marijuana stock to the next level.

Though Canopy Growth stock is down ~10% this year, it’s still up more than 140% during the past year — a performance that’s hard to match by other growth stocks.

Going forward, it appears that investors are not exactly keen to speculate on marijuana stocks, especially when the deadline for the legalization of recreational pot is fast approaching. The price action in the marijuana space suggests that stocks of Canada’s largest pot producers have lost their momentum of the past year.

I believe that investors who are still hoping to make massive gains by speculating on marijuana stocks are a little late to the pot party. With valuations soaring, it’s tough for rational investors to put their money on this trade.

Lofty valuations   

The average price-to-book ratio of Canopy, for example is 5.2, or about three times the S&P/Toronto Stock Exchange Composite Index’ P/B ratio of 1.8. Its price-to-sales ratio is 83, a staggering 49 times the Index’ P/S ratio of 1.7.

With these lofty valuations, marijuana companies must be extremely smart in order to execute their sales strategies once the recreational market is ready. Canopy Growth, however, is well positioned to benefit from a potential surge in demand. Canopy’s latest earnings report showed that the company already has a great deal of momentum.

Ontario-based Smiths Falls said its revenue rose to $21.7 million for the quarter ended December 31 — more than double the $9.8 million earned in the last three months of 2016.

The company also reported a 138% jump in its active registered patients to 69,000, up from 29,000 a year ago. The growth came as Canopy’s profits attributable to the company narrowed to $1.6 million, or one cent per diluted share, up from nearly $3 million, or two cents per diluted share, a year ago.

The bottom line

In 2017, investors’ psychology last drove a remarkable rally in pot stocks, which tells us that investors usually overreact in both positive and negative situations.

As I’ve discussed in my earlier articles, all the good news has already been priced into marijuana stocks, and it would therefore be unrealistic to expect a similar performance this year. As the market focus shifts to the execution, it’s better for investors to wait on the sidelines.

For long-term investors, however, Canopy Growth stock could prove to be a good investment if we don’t see too much competition from new entrants. Trading at $28.99 at the time of writing, Canopy stock is still expensive. I would therefore wait for a more attractive level before taking any position.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no position in the companies mentioned.

More on Investing

stocks climbing green bull market
Stocks for Beginners

3 TSX Stocks Soaring Higher With No Signs of Slowing

Don't ignore stocks just because they look like they're at a high price. Instead, see exactly why they've driven so…

Read more »

dividends can compound over time
Bank Stocks

Is TD Bank Stock a Buy for Its 5.2% Dividend Yield?

TD Bank stock offers a rare 5.2% dividend yield—can it rebound from challenges and reward contrarian investors? Here's what to…

Read more »

chart reflected in eyeglass lenses
Investing

How Should a Beginner Invest in Stocks? Start With This Index Fund

This Vanguard index fund is the perfect way to start a Canadian investment portfolio.

Read more »

analyze data
Bank Stocks

Is BMO Stock a Buy for its 4.7% Dividend Yield?

Bank of Montreal is up 20% since late August. Are more gains on the way?

Read more »

Middle aged man drinks coffee
Dividend Stocks

Here’s the Average TFSA Balance at Age 35 in Canada

At age 35, it might not seem like you need to be thinking about your future cash flow. But ideally,…

Read more »

A person uses and AI chat bot
Tech Stocks

AI Where No One’s Looking: Seize Growth in These Canadian Stocks Before the Market Catches Up

Beyond flashy headlines about generative AI, these two Canadian AI stocks could deliver strong returns for investors who are willing…

Read more »

Rocket lift off through the clouds
Investing

2 Small-Cap Stocks That Canadians Should Consider in November

Small-cap stocks can have explosive upside. However, you need to be very choosey. Here are two small cap Canadian stocks…

Read more »

Middle aged man drinks coffee
Stock Market

Top Canadian Stocks You Can Buy Now With Just $1,000

Undervalued Canadian stocks such as Lassonde and Jamieson Wellness trade at a sizeable discount to consensus price target estimates.

Read more »